Clinical trial
Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking
NCT00248118 · National Institute on Drug Abuse (NIDA), NIH · Terminated
Key facts
| NCT number | NCT00248118 |
|---|---|
| Title | Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking |
| Official title | Neurocognitive and Affective Correlates of Tobacco Dependence in Adolescent Smokers and Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Tobacco Dependence |
| Intervention type | Drug |
| Interventions | Bupropion |
| Enrollment | 72 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Nov 3, 2005 |
| Last update posted | Sep 23, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: